Immunovant, Inc. (IMVT)
NASDAQ·Healthcare·Biotechnology
$34.51
-7.47%
Mkt Cap $7.67B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (10 analysts)
$40.00
Range $40.00 – $40.00
Implied Upside
+15.9%
Consensus $40.00 vs current $34.51
NASDAQ·Healthcare·Biotechnology
$34.51
-7.47%
Mkt Cap $7.67B
Buy
5
Hold
2
Sell
0
Price Target (10 analysts)
$40.00
Range $40.00 – $40.00
+15.9%
Consensus $40.00 vs current $34.51